Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liver. Seo HY, Lee SH, Park JY, Han E, et al. PLoS One 2023;18:e0290532.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Seo HY, Lee SH, Park JY, Han E, et al. Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liver. PLoS One 2023;18:e0290532.
PMID: 37616215